4.5 Article

Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation

Related references

Note: Only part of the references are listed.
Article Substance Abuse

Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 x 2 factorial, randomized, placebo-controlled trial

Brian Hitsman et al.

Summary: This study compared the efficacy and safety of behavioral activation, varenicline, and their combination for smoking cessation. The results showed that varenicline was more effective in promoting smoking abstinence compared to placebo at 27 weeks without increasing adverse events. However, behavioral activation did not outperform standard behavioral treatment for smoking cessation.

ADDICTION (2023)

Review Psychology, Clinical

Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness

Mark R. Hawes et al.

Summary: Studies on smoking cessation interventions for individuals with serious mental illness showed that providing smoking cessation medications, motivational enhancements, and cessation education are common effective components. However, methodological limitations and a small number of studies finding significant between-group differences hinder the identification of the most effective psychosocial smoking cessation interventions.

JOURNAL OF DUAL DIAGNOSIS (2021)

Article Psychology, Clinical

Medication adherence and rate of nicotine metabolism are associated with response to treatment with varenicline among smokers with HIV

Anna-Marika Bauer et al.

Summary: In a randomized controlled trial of varenicline for smoking among PLWHA, adherence to treatment and rate of nicotine metabolism were found to be associated with smoking cessation rates. Higher adherence and faster nicotine metabolism were related to higher quit rates, especially among adherent and fast metabolizers. Increasing adherence to varenicline and providing it to fast nicotine metabolizers may increase quit rates for PLWHA.

ADDICTIVE BEHAVIORS (2021)

Article Substance Abuse

Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events,Treatment Adherence, and Smoking Cessation

John B. Correa et al.

Summary: Having multiple psychiatric diagnoses increases the risk of developing moderate-to-severe neuropsychiatric adverse events during a quit attempt. However, neither psychiatric comorbidity (CM) nor multimorbidity (MM) were associated with treatment adherence or odds of quitting. These findings suggest that smokers with stable psychiatric conditions should consider using FDA-approved medications when trying to quit.

NICOTINE & TOBACCO RESEARCH (2021)

Article Public, Environmental & Occupational Health

Trends in the Prevalence of Current, Daily, and Nondaily Cigarette Smoking and Quit Ratios by Depression Status in the US: 2005-2017

Andrea H. Weinberger et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)

Article Psychology, Clinical

Measures and predictors of varenicline adherence in the treatment of nicotine dependence

Annie R. Peng et al.

ADDICTIVE BEHAVIORS (2017)

Article Health Care Sciences & Services

Adherence to Varenicline and Associated Smoking Cessation in a Community-Based Patient Setting

Joshua N. Liberman et al.

JOURNAL OF MANAGED CARE PHARMACY (2013)

Article Education & Educational Research

Treatment adherence in a lay health adviser intervention to treat tobacco dependence

N. E. Hood et al.

HEALTH EDUCATION RESEARCH (2013)

Article Psychology, Clinical

The Origins and Current Status of Behavioral Activation Treatments for Depression

Sona Dimidjian et al.

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY (2011)

Review Health Care Sciences & Services

Depression and Medication Adherence in the Treatment of Chronic Diseases in the United States: A Meta-Analysis

Jerry L. Grenard et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2011)

Article Substance Abuse

Adherence to Varenicline in the COMPASS Smoking Cessation Intervention Trial

Sheryl L. Catz et al.

NICOTINE & TOBACCO RESEARCH (2011)

Article Health Care Sciences & Services

Predictors of Adherence to Nicotine Gum and Counseling among African-American Light Smokers

Kolawole S. Okuyemi et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2010)

Article Psychology, Clinical

A psychometric evaluation of the Fagerstrom Test for Nicotine Dependence in PTSD smokers

TC Buckley et al.

ADDICTIVE BEHAVIORS (2005)

Article Psychology, Clinical

A brief behavioral activation treatment for depression - Treatment manual

CW Lejuez et al.

BEHAVIOR MODIFICATION (2001)

Review Clinical Neurology

Smoking cessation in women - Special considerations

KA Perkins

CNS DRUGS (2001)